Providence Medical Research Center :: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. :: Spokane, WA

You Are Here: Home

Recent Publications

2001

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

2001

Study Keyword Search

Lewis EJ, et al. for the Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-859, 2001.

Notice of Privacy Practices
Providence Sacred Heart Medical Center | Joint Commission Notice | Joint Commission Web Site
© Copyright 2009 Providence Medical Research Center